The third event in the Symposia series showcased the vaccine projects supported by the Bloomsbury SET programme.
The event was chaired by Professor Dirk Werling, RVC with the following programme:
Introduction to the Bloomsbury SET by Dr Ray Kent, RVC
Vaccine research to commercialisation: the funder’s perspective by Dr Phil Packer, Innovate UK
Development of low-cost glycoconjugate vaccines for pigs by Professor Brendan Wren, LSHTM
Development of a poultry vaccine platform based on transgenic coccidia parasites and evaluation of immunoprotection against necrotic enteritis by Dr Virginia Marugan-Hernandez, RVC
Multidisciplinary research for the strategic and translational development of late-stage tuberculosis vaccine candidates by Professor Richard White, LSHTM and Puck Pelzer, KNCV Tuberculosis Foundation.
Back